Israel Englander’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-72,588
| Closed | -$123K | – | 6340 |
|
|
2026
Q1 | $123K | Sell |
72,588
-201,811
| -74% | -$415K | ﹤0.01% | 5307 |
|
|
2025
Q4 | $543K | Sell |
274,399
-44,487
| -14% | -$142K | ﹤0.01% | 4891 |
|
|
2025
Q3 | $928K | Sell |
318,886
-153,896
| -33% | -$354K | ﹤0.01% | 4685 |
|
|
2025
Q2 | $856K | Buy |
+472,782
| New | +$841K | ﹤0.01% | 4523 |
|
|
2025
Q1 | – | Sell |
-29,456
| Closed | -$69.5K | – | 6339 |
|
|
2024
Q4 | $69.5K | Buy |
+29,456
| New | +$517K | ﹤0.01% | 5540 |
|
|
2024
Q1 | – | Sell |
-66,885
| Closed | -$1.43M | – | 6587 |
|
|
2023
Q4 | $1.43M | Buy |
+66,885
| New | +$1.41M | ﹤0.01% | 3870 |
|
|
2023
Q3 | – | Sell |
-9,313
| Closed | -$228K | – | 6503 |
|
|
2023
Q2 | $228K | Sell |
9,313
-44,779
| -83% | -$1.08M | ﹤0.01% | 5047 |
|
|
2023
Q1 | $1.3M | Buy |
54,092
+33,190
| +159% | +$920K | ﹤0.01% | 3842 |
|
|
2022
Q4 | $617K | Buy |
20,902
+11,851
| +131% | +$426K | ﹤0.01% | 4578 |
|
|
2022
Q3 | $379K | Buy |
+9,051
| New | +$244K | ﹤0.01% | 5191 |
|
|
2021
Q4 | – | Sell |
-116,851
| Closed | -$7.25M | – | 7315 |
|
|
2021
Q3 | $7.25M | Buy |
116,851
+72,936
| +166% | +$6.09M | ﹤0.01% | 2439 |
|
|
2021
Q2 | $3.75M | Sell |
43,915
-185,061
| -81% | -$9.91M | ﹤0.01% | 3143 |
|
|
2021
Q1 | $10.3M | Buy |
+228,976
| New | +$9.01M | 0.01% | 1745 |
|
|
2020
Q2 | – | Sell |
-255,600
| Closed | -$1.05M | – | 4544 |
|
|
2020
Q1 | $1.05M | Buy |
255,600
+228,881
| +857% | +$1.52M | ﹤0.01% | 2438 |
|
|
2019
Q4 | $139K | Buy |
+26,719
| New | +$46.1K | ﹤0.01% | 3958 |
|
|
2016
Q1 | – | Sell |
-3,917
| Closed | -$48K | – | 3614 |
|
|
2015
Q4 | $48K | Sell |
3,917
-10,573
| -73% | -$140K | ﹤0.01% | 3309 |
|
|
2015
Q3 | $186K | Sell |
14,490
-168
| -1% | -$2.12K | ﹤0.01% | 3136 |
|
|
2015
Q2 | $178K | Buy |
14,658
+3,683
| +34% | +$50.5K | ﹤0.01% | 3074 |
|
|
2015
Q1 | $145K | Sell |
10,975
-14,025
| -56% | -$189K | ﹤0.01% | 3360 |
|
|
2014
Q4 | $355K | Buy |
+25,000
| New | +$433K | ﹤0.01% | 3241 |
|
|
2014
Q3 | – | Sell |
-12,664
| Closed | -$510K | – | 3968 |
|
|
2014
Q2 | $510K | Buy |
+12,664
| New | +$469K | ﹤0.01% | 2576 |
|
|
2014
Q1 | – | Sell |
-5,547
| Closed | -$189K | – | 3830 |
|
|
2013
Q4 | $189K | Buy |
+5,547
| New | +$147K | ﹤0.01% | 3264 |
|
|
2013
Q3 | – | Sell |
-1,586
| Closed | -$25K | – | 3539 |
|
|
2013
Q2 | $25K | Buy |
+1,586
| New | +$33.5K | ﹤0.01% | 2931 |
|
Other funds holding FLNA
GC
Israel Englander's FLNA Position: Q2 2026 in Review
Israel Englander sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 72,588 shares — an estimated $123K sold.
Israel Englander first reported a position in FLNA in Q2 2013 and held it in 23 quarters. The position peaked at $10.3M in Q1 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- Israel Englander reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 72,588 Filana Therapeutics shares in Q2 2026, an estimated $123K.
- Israel Englander first reported a position in Filana Therapeutics in Q2 2013 and held it in 23 quarters.
- Israel Englander's Filana Therapeutics position peaked at $10.3M in Q1 2021.
- 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.